Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility-a review
- 1 June 1995
- journal article
- review article
- Published by Elsevier BV in Gene
- Vol. 159 (1), 113-121
- https://doi.org/10.1016/0378-1119(94)00448-2
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Restriction fragment length polymorphism of the human CYP 2E1 (cytochrome P450IIE1) gene and susceptibility to lung cancerPharmacogenetics, 1994
- 1462V mutation in the human CYP1A1 genePharmacogenetics, 1994
- B- and T-lymphocyte micronuclei in chimney sweeps with respect to genetic polymorphism for CYP1A1 and GST1 (class Mu)Mutation Research, 1993
- N-Acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workersCarcinogenesis: Integrative Cancer Research, 1993
- Characterization of a human cell line expressing high levels of cDNA-derived CYP2D6Pharmacogenetics, 1993
- The human CYP2E1 gene and lung cancer: DraI and RsaI restriction fragment length polymorphisms in a Finish study populationCarcinogenesis: Integrative Cancer Research, 1993
- The P450 Superfamily: Update on New Sequences, Gene Mapping, Accession Numbers, Early Trivial Names of Enzymes, and NomenclatureDNA and Cell Biology, 1993
- An Mspl RFLP in the human ARNT gene, encoding a subunit of the nuclear form of the Ah (dioxin) receptorHuman Molecular Genetics, 1992
- Identification of the primary gene defect at the cytochrome P450 CYP2D locusNature, 1990
- Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P45 0IA1 geneFEBS Letters, 1990